Multimodal Optical Imaging to Investigate Spatiotemporal Changes in Cerebrovascular Function in AUDA Treatment of Acute Ischemic Stroke

Han Lin Wang; Jia Wei Chen; Shih Hung Yang; Yu Chun Lo; Han Chi Pan; Yao Wen Liang; Ching Fu Wang; Yi Yang; Yun Ting Kuo; Yi Chen Lin; Chin Yu Chou; Sheng Huang Lin; You Yin Chen

doi:10.3389/fncel.2021.655305

Multimodal Optical Imaging to Investigate Spatiotemporal Changes in Cerebrovascular Function in AUDA Treatment of Acute Ischemic Stroke

Han Lin Wang, Jia Wei Chen, Shih Hung Yang, Yu Chun Lo, Han Chi Pan, Yao Wen Liang, Ching Fu Wang, Yi Yang, Yun Ting Kuo, Yi Chen Lin, Chin Yu Chou, Sheng Huang Lin, You Yin Chen

研究成果: 雜誌貢獻 › 文章 › 同行評審

3 引文斯高帕斯（Scopus）

摘要

Administration of 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA) has been demonstrated to alleviate infarction following ischemic stroke. Reportedly, the main effect of AUDA is exerting anti-inflammation and neovascularization via the inhibition of soluble epoxide hydrolase. However, the major contribution of this anti-inflammation and neovascularization effect in the acute phase of stroke is not completely elucidated. To investigate the neuroprotective effects of AUDA in acute ischemic stroke, we combined laser speckle contrast imaging and optical intrinsic signal imaging techniques with the implantation of a lab-designed cranial window. Forepaw stimulation was applied to assess the functional changes via measuring cerebral metabolic rate of oxygen (CMRO₂) that accompany neural activity. The rats that received AUDA in the acute phase of photothrombotic ischemia stroke showed a 30.5 ± 8.1% reduction in the ischemic core, 42.3 ± 15.1% reduction in the ischemic penumbra (p < 0.05), and 42.1 ± 4.6% increase of CMRO₂ in response to forepaw stimulation at post-stroke day 1 (p < 0.05) compared with the control group (N = 10 for each group). Moreover, at post-stroke day 3, increased functional vascular density was observed in AUDA-treated rats (35.9 ± 1.9% higher than that in the control group, p < 0.05). At post-stroke day 7, a 105.4% ± 16.4% increase of astrocytes (p < 0.01), 30.0 ± 10.9% increase of neurons (p < 0.01), and 65.5 ± 15.0% decrease of microglia (p < 0.01) were observed in the penumbra region in AUDA-treated rats (N = 5 for each group). These results suggested that AUDA affects the anti-inflammation at the beginning of ischemic injury and restores neuronal metabolic rate of O₂ and tissue viability. The neovascularization triggered by AUDA restored CBF and may contribute to ischemic infarction reduction at post-stroke day 3. Moreover, for long-term neuroprotection, astrocytes in the penumbra region may play an important role in protecting neurons from apoptotic injury.

原文	英語
文章編號	655305
期刊	Frontiers in Cellular Neuroscience
卷	15
DOIs	https://doi.org/10.3389/fncel.2021.655305
出版狀態	已發佈 - 6月 3 2021

ASJC Scopus subject areas

細胞與分子神經科學

存取文件

10.3389/fncel.2021.655305

其它文件與鏈接

Link to publication in Scopus

引用此

Wang, H. L., Chen, J. W., Yang, S. H., Lo, Y. C., Pan, H. C., Liang, Y. W., Wang, C. F., Yang, Y., Kuo, Y. T., Lin, Y. C., Chou, C. Y., Lin, S. H., & Chen, Y. Y. (2021). Multimodal Optical Imaging to Investigate Spatiotemporal Changes in Cerebrovascular Function in AUDA Treatment of Acute Ischemic Stroke. Frontiers in Cellular Neuroscience, 15, 文章 655305. https://doi.org/10.3389/fncel.2021.655305

@article{7acf7033418845ad973e165385b04d5f,

title = "Multimodal Optical Imaging to Investigate Spatiotemporal Changes in Cerebrovascular Function in AUDA Treatment of Acute Ischemic Stroke",

abstract = "Administration of 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA) has been demonstrated to alleviate infarction following ischemic stroke. Reportedly, the main effect of AUDA is exerting anti-inflammation and neovascularization via the inhibition of soluble epoxide hydrolase. However, the major contribution of this anti-inflammation and neovascularization effect in the acute phase of stroke is not completely elucidated. To investigate the neuroprotective effects of AUDA in acute ischemic stroke, we combined laser speckle contrast imaging and optical intrinsic signal imaging techniques with the implantation of a lab-designed cranial window. Forepaw stimulation was applied to assess the functional changes via measuring cerebral metabolic rate of oxygen (CMRO2) that accompany neural activity. The rats that received AUDA in the acute phase of photothrombotic ischemia stroke showed a 30.5 ± 8.1% reduction in the ischemic core, 42.3 ± 15.1% reduction in the ischemic penumbra (p < 0.05), and 42.1 ± 4.6% increase of CMRO2 in response to forepaw stimulation at post-stroke day 1 (p < 0.05) compared with the control group (N = 10 for each group). Moreover, at post-stroke day 3, increased functional vascular density was observed in AUDA-treated rats (35.9 ± 1.9% higher than that in the control group, p < 0.05). At post-stroke day 7, a 105.4% ± 16.4% increase of astrocytes (p < 0.01), 30.0 ± 10.9% increase of neurons (p < 0.01), and 65.5 ± 15.0% decrease of microglia (p < 0.01) were observed in the penumbra region in AUDA-treated rats (N = 5 for each group). These results suggested that AUDA affects the anti-inflammation at the beginning of ischemic injury and restores neuronal metabolic rate of O2 and tissue viability. The neovascularization triggered by AUDA restored CBF and may contribute to ischemic infarction reduction at post-stroke day 3. Moreover, for long-term neuroprotection, astrocytes in the penumbra region may play an important role in protecting neurons from apoptotic injury.",

keywords = "AUDA, cranial window, ischemic stroke, multimodal optical imaging system, neovascularization, penumbra",

author = "Wang, {Han Lin} and Chen, {Jia Wei} and Yang, {Shih Hung} and Lo, {Yu Chun} and Pan, {Han Chi} and Liang, {Yao Wen} and Wang, {Ching Fu} and Yi Yang and Kuo, {Yun Ting} and Lin, {Yi Chen} and Chou, {Chin Yu} and Lin, {Sheng Huang} and Chen, {You Yin}",

note = "Funding Information: We also are grateful for support from the Higher Education Sprout Project of the National Chiao Tung University, Headquarters of University Advancement at the National Cheng Kung University, Ministry of Education (MOE), Taiwan, and TCMF-MP 108-01-03, Buddhist Tzu Chi Medical Foundation. Funding. This work is financially supported by Ministry of Science and Technology of Taiwan under Contract numbers of MOST 110-2321-B-010-006, 109-2221-E-010-004-MY2, 109-2314-B-303-016, and 109-2636-E-006-010 (Young Scholar Fellowship Program), and 108-2321-B-010-008-MY2. Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2021 Wang, Chen, Yang, Lo, Pan, Liang, Wang, Yang, Kuo, Lin, Chou, Lin and Chen.",

year = "2021",

month = jun,

day = "3",

doi = "10.3389/fncel.2021.655305",

language = "English",

volume = "15",

journal = "Frontiers in Cellular Neuroscience",

issn = "1662-5102",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Multimodal Optical Imaging to Investigate Spatiotemporal Changes in Cerebrovascular Function in AUDA Treatment of Acute Ischemic Stroke

AU - Wang, Han Lin

AU - Chen, Jia Wei

AU - Yang, Shih Hung

AU - Lo, Yu Chun

AU - Pan, Han Chi

AU - Liang, Yao Wen

AU - Wang, Ching Fu

AU - Yang, Yi

AU - Kuo, Yun Ting

AU - Lin, Yi Chen

AU - Chou, Chin Yu

AU - Lin, Sheng Huang

AU - Chen, You Yin

N1 - Funding Information: We also are grateful for support from the Higher Education Sprout Project of the National Chiao Tung University, Headquarters of University Advancement at the National Cheng Kung University, Ministry of Education (MOE), Taiwan, and TCMF-MP 108-01-03, Buddhist Tzu Chi Medical Foundation. Funding. This work is financially supported by Ministry of Science and Technology of Taiwan under Contract numbers of MOST 110-2321-B-010-006, 109-2221-E-010-004-MY2, 109-2314-B-303-016, and 109-2636-E-006-010 (Young Scholar Fellowship Program), and 108-2321-B-010-008-MY2. Publisher Copyright: © Copyright © 2021 Wang, Chen, Yang, Lo, Pan, Liang, Wang, Yang, Kuo, Lin, Chou, Lin and Chen.

PY - 2021/6/3

Y1 - 2021/6/3

N2 - Administration of 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA) has been demonstrated to alleviate infarction following ischemic stroke. Reportedly, the main effect of AUDA is exerting anti-inflammation and neovascularization via the inhibition of soluble epoxide hydrolase. However, the major contribution of this anti-inflammation and neovascularization effect in the acute phase of stroke is not completely elucidated. To investigate the neuroprotective effects of AUDA in acute ischemic stroke, we combined laser speckle contrast imaging and optical intrinsic signal imaging techniques with the implantation of a lab-designed cranial window. Forepaw stimulation was applied to assess the functional changes via measuring cerebral metabolic rate of oxygen (CMRO2) that accompany neural activity. The rats that received AUDA in the acute phase of photothrombotic ischemia stroke showed a 30.5 ± 8.1% reduction in the ischemic core, 42.3 ± 15.1% reduction in the ischemic penumbra (p < 0.05), and 42.1 ± 4.6% increase of CMRO2 in response to forepaw stimulation at post-stroke day 1 (p < 0.05) compared with the control group (N = 10 for each group). Moreover, at post-stroke day 3, increased functional vascular density was observed in AUDA-treated rats (35.9 ± 1.9% higher than that in the control group, p < 0.05). At post-stroke day 7, a 105.4% ± 16.4% increase of astrocytes (p < 0.01), 30.0 ± 10.9% increase of neurons (p < 0.01), and 65.5 ± 15.0% decrease of microglia (p < 0.01) were observed in the penumbra region in AUDA-treated rats (N = 5 for each group). These results suggested that AUDA affects the anti-inflammation at the beginning of ischemic injury and restores neuronal metabolic rate of O2 and tissue viability. The neovascularization triggered by AUDA restored CBF and may contribute to ischemic infarction reduction at post-stroke day 3. Moreover, for long-term neuroprotection, astrocytes in the penumbra region may play an important role in protecting neurons from apoptotic injury.

AB - Administration of 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA) has been demonstrated to alleviate infarction following ischemic stroke. Reportedly, the main effect of AUDA is exerting anti-inflammation and neovascularization via the inhibition of soluble epoxide hydrolase. However, the major contribution of this anti-inflammation and neovascularization effect in the acute phase of stroke is not completely elucidated. To investigate the neuroprotective effects of AUDA in acute ischemic stroke, we combined laser speckle contrast imaging and optical intrinsic signal imaging techniques with the implantation of a lab-designed cranial window. Forepaw stimulation was applied to assess the functional changes via measuring cerebral metabolic rate of oxygen (CMRO2) that accompany neural activity. The rats that received AUDA in the acute phase of photothrombotic ischemia stroke showed a 30.5 ± 8.1% reduction in the ischemic core, 42.3 ± 15.1% reduction in the ischemic penumbra (p < 0.05), and 42.1 ± 4.6% increase of CMRO2 in response to forepaw stimulation at post-stroke day 1 (p < 0.05) compared with the control group (N = 10 for each group). Moreover, at post-stroke day 3, increased functional vascular density was observed in AUDA-treated rats (35.9 ± 1.9% higher than that in the control group, p < 0.05). At post-stroke day 7, a 105.4% ± 16.4% increase of astrocytes (p < 0.01), 30.0 ± 10.9% increase of neurons (p < 0.01), and 65.5 ± 15.0% decrease of microglia (p < 0.01) were observed in the penumbra region in AUDA-treated rats (N = 5 for each group). These results suggested that AUDA affects the anti-inflammation at the beginning of ischemic injury and restores neuronal metabolic rate of O2 and tissue viability. The neovascularization triggered by AUDA restored CBF and may contribute to ischemic infarction reduction at post-stroke day 3. Moreover, for long-term neuroprotection, astrocytes in the penumbra region may play an important role in protecting neurons from apoptotic injury.

KW - AUDA

KW - cranial window

KW - ischemic stroke

KW - multimodal optical imaging system

KW - neovascularization

KW - penumbra

UR - http://www.scopus.com/inward/record.url?scp=85108166871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108166871&partnerID=8YFLogxK

U2 - 10.3389/fncel.2021.655305

DO - 10.3389/fncel.2021.655305

M3 - Article

AN - SCOPUS:85108166871

SN - 1662-5102

VL - 15

JO - Frontiers in Cellular Neuroscience

JF - Frontiers in Cellular Neuroscience

M1 - 655305

ER -

Multimodal Optical Imaging to Investigate Spatiotemporal Changes in Cerebrovascular Function in AUDA Treatment of Acute Ischemic Stroke

摘要

ASJC Scopus subject areas

存取文件

其它文件與鏈接

指紋

引用此